Dose Finding Trial of R21/Matrix-M in School Children

NCT07074665 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Malaria (Plasmodium Falciparum)

Interventions

BIOLOGICAL: 5µg R21/50µg Matrix-M
BIOLOGICAL: 10µg R21/50µg Matrix-M

Sponsor

University of Oxford

Collaborators

[object Object]